Clinical Trial

THE-0504 in Patients With Solid Tumors

Name: THE-0504 in Patients With Solid Tumors — clinical trial record (NCT07646106)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.

Trial Details

NCT Number	NCT07646106
Lead Sponsor	Thena Biotech S.r.l.
Conditions	Small Cell Lung Cancer (SCLC), Colorectal Carcinoma (CRC), Gastric Cancer (GC), Triple -Negative Breast Cancer, Pancreas Adenocarcinoma
Enrollment	30 participants
Start Date	2024-11-13
Primary Completion	2027-05-01 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-12